10 Apr 2019

Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

NaTHNaC receives reassurance that contingencies for continuous yellow fever vaccine supply to the UK are robust and sustainable in the event of a ‘no deal’ EU Exit Notice for Yellow Fever Vaccination Centres: Leaving the EU – yellow fever vaccine supply

On behalf of Yellow Fever Vaccination Centres (YFVC) in England, Wales and Northern Ireland, NaTHNaC has been working closely with Sanofi Pasteur who manufacture, pack and supply yellow fever vaccine in France for the UK market. Sanofi Pasteur advises that their contingency plan for a ‘no deal’ EU Exit includes increasing yellow fever vaccine stock levels and securing alternative and robust supply lines into the UK.

Local stockpiling is unnecessary and YFVC should continue to order YF vaccine as usual.

Further updates will be provided when available.

Resources

Heatwave alert for mainland Europe

Hot weather advice for travellers to mainland European countries Read more

E.coli advice for travellers to Egypt

Public Health England has issued advice to people travelling to Egypt Read more

DRC: Ebola outbreak declared a Public Health Emergency of International Concern

The meeting of the Emergency Committee convened by the WHO Director General under International Health Regulations took place on Wednesday 17 July 2019 Read more

Ghana: updated recommendations for polio vaccination

Circulating vaccine derived poliovirus type 2 (cVDPV) has been detected in an environmental sample during routine surveillance Read more

Rabies case in Vancouver Island, British Columbia, Canada

A case of human rabies as been reported following exposure to a bat on Vancouver Island Read more
Back to Top

VIEW FULL INDEX